Tag Archives: Medical Devices

FDA Gets More Funding, IPAB Gets Less

After two years in budget limbo, Congress finally enacted federal spending legislation for fiscal year 2014 last week, just before the latest funding extension ran out. In this period of ever-tighter government outlays, the Food and Drug Administration did fairly well in gaining additional funds, along with user fee revenues that had been put on […]
Posted in FDA, healthcare, Legal, Regulatory, Safety | Also tagged , , , , , , , | Leave a comment

Europe: New Device and Diagnostics Legislation Could Shake Up the Drug Industry

EuropeNew Device and Diagnostics Legislation Will Shake Up Drug Industry The shockwaves from the current European Union debates in Brussels on medical devices are are likely to echo through the medicines business over the next few years. This month, the European parliament’s health committee will reach its view on the two major proposals launched last […]
Posted in Europe, Op-Ed, Regulatory | Also tagged , , , | 1 Comment

Enhancing Racial Diversity in Clinical Trials

In August of 2013, the FDA released a report that analyzed clinical trial subject demographic subgroups for FDA approved medical products, which included factors such as race, age and gender.  After reviewing the report in detail, I started thinking about the importance of incorporating diversity into clinical trials. What Did the Report Find???This report analyzed […]
Posted in Guest Blog, Op-Ed, R&D | Also tagged , | Leave a comment

Despite Growing Momentum, Repeal of Medical Device Tax Faces Significant Hurdles

by William Kitchens On March 21, 2013, the United States Senate approved an amendment by a vote of 79 to 20 to repeal the 2.3 percent medical device excise tax. The tax, which went into effect this past January, was included as part of the Patient Protection and Affordable Care Act.
Posted in Strategy | Also tagged , , , , | Leave a comment

For Becton Dickinson, Medication Errors are a Business Opportunity

Over the next few years, med tech company Becton Dickinson will launch up to 30 generic, pre-filled syringes in an attempt to lower medication errors and raise company revenues, according to BD Rx president Mark Sebree. One man’s goof is another man’s growth, potentially.
Posted in FDA, Manufacturing, pricing, R&D, Safety, Strategy, Technology | Also tagged , , , , | Leave a comment
  • Categories

  • Meta